Cell Reports (Jun 2013)

Mutant Mice Lacking the p53 C-Terminal Domain Model Telomere Syndromes

  • Iva Simeonova,
  • Sara Jaber,
  • Irena Draskovic,
  • Boris Bardot,
  • Ming Fang,
  • Rachida Bouarich-Bourimi,
  • Vincent Lejour,
  • Laure Charbonnier,
  • Claire Soudais,
  • Jean-Christophe Bourdon,
  • Michel Huerre,
  • Arturo Londono-Vallejo,
  • Franck Toledo

DOI
https://doi.org/10.1016/j.celrep.2013.05.028
Journal volume & issue
Vol. 3, no. 6
pp. 2046 – 2058

Abstract

Read online

Mutations in p53, although frequent in human cancers, have not been implicated in telomere-related syndromes. Here, we show that homozygous mutant mice expressing p53Δ31, a p53 lacking the C-terminal domain, exhibit increased p53 activity and suffer from aplastic anemia and pulmonary fibrosis, hallmarks of syndromes caused by short telomeres. Indeed, p53Δ31/Δ31 mice had short telomeres and other phenotypic traits associated with the telomere disease dyskeratosis congenita and its severe variant the Hoyeraal-Hreidarsson syndrome. Heterozygous p53+/Δ31 mice were only mildly affected, but decreased levels of Mdm4, a negative regulator of p53, led to a dramatic aggravation of their symptoms. Importantly, several genes involved in telomere metabolism were downregulated in p53Δ31/Δ31 cells, including Dyskerin, Rtel1, and Tinf2, which are mutated in dyskeratosis congenita, and Terf1, which is implicated in aplastic anemia. Together, these data reveal that a truncating mutation can activate p53 and that p53 plays a major role in the regulation of telomere metabolism.